The global ophthalmic surgical technologies market size USD 982.2 million and expected to reach USD 1,380.2 million by 2028, at a CAGR of 5.92% during the forecast period 2022-2028. Ophthalmic surgery or ocular surgery is performed on eye or its adnexa. Most common eye disorders are glaucoma, cataract, and diabetic retinopathy. Ophthalmic Surgical Technologies Market are carried by various technologies such as femtosecond system, excimer laser systems, and laser ophthalmic surgical systems among others. Global ophthalmic surgical technologies market is poised to grow at a significant CAGR owing to increase in the prevalence of ophthalmic diseases. According to World Health Organization 2017, approximately 253 Mn people are living with vision impairment, 36 Mn are blind, and 217 Mn are suffering from moderate to severe impairment. Moreover, development of newer technologies with minimally invasive surgical procedures expected to upsurge the revenue of ophthalmic surgical technologies market. For instance, in November 2015, Alcon, a division of Novartis, introduced Contoura Vision, a latest advancement in wavelight refractive portfolio to treat nearsightedness or nearsightedness with astigmatism in patients by using laser procedure. Moreover, market players acquiring the competitors business to strengthen their market position. For instance, in September 2016, Johnson & Johnson acquired Abbott Medical Optics business segment including laser refractive surgery, cataract surgery, and consumer eye health.
In October 2017, Zeiss introduced new technologies for advancing ophthalmic care including new all-in-one Opmi Lumera 700 surgical microscope, next-generation EDoF IOL, and Clarus 500 ultra-widefield imaging